Be Bio

Developer of B cell therapies for multiple therapeutic areas

placeCambridge, Massachusetts, United States calendar_todayFounded 2020 groups103 employees language be.bio

Social engagement

Social engagement: 10.3K social following, 2 posts in the last 12 months — below the industry typical range.

Investor mix

9 investors on record; lead investors include Arch Venture Partners, Atlas Venture, RA Capital Management, Nextech Invest.

Investor typeCountShare
Venture capital556%
Private equity111%
Other / undisclosed333%
Coming soon